1Raghavan M, Marik PE. Management of sepsis during the early "golden hours". J Emerg Med, 2006,31(2) : 185-199.
2Dellinger RP, Levy MM, Carlet JM, et at. Surviving sepsis campaign: international guidelines for management of severe sep- sisand septic shock: 2008. Intensive Care Med, 2008,34(1):17- 60.
3Gunn SR, Pinsky MR. Implications of arterial pressure variation in patients in the intensive care unit. Curr ()pin Crit Care,2001, 7(3) :212-217.
4De Backer D, Biston P, Devriendt J, et al. Comparison of dopa- mine and norepinephrine in the treatment of shock. N Engl J Med, 2010, 362(9):779-789.
5Martin C, Viviand X, Leone M, et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med, 2000, 28 (8): 2758-2765.
6Raja SG, Rayen BS. Levosimendan in cardiac surgery: current best available evidence. Ann Thorac Surg, 2006, 81 (4) : 1536- 1546.
7Powell BP, De Keulenaer BL. Levosimendan in septic shock a ease series. Br J Anaesth,2007,99(3) :447-448.
8Tyagi A, Sethi AK, Girotra G, et al. The Microcirculation in Sepsis. Indian J Anaesth, 2009,53 (3) : 281 293.
9Ospina--Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med, 2010,36 (6) : 949-955.
10Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamies, oxygen transport, and nitric oxide. Crit Care, 2003,7(5) :359-373.
